Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride

Table 4

Recovery studies for EMT, TDF, and RPV.

Con (%)	Added amount (mg)			Amount recovered (mg)			Amount recovered (%)
	EMT	TDF	RPV	EMT	TDF	RPV	EMT	TDF	RPV
50	10	15	1.25	9.950	15.18	1.232	99.51	101.96	98.72
75	15	22.5	1.875	14.99	22.66	1.874	99.94	100.75	99.94
100	20	30	2.5	20.20	29.53	2.526	101.03	98.44	101.04
125	25	37.5	3.125	25.14	37.64	3.062	101.27	100.38	98.00
150	30	45	3.75	30.07	44.50	3.81	100.26	98.90	101.98